BRPI0720077A2 - Formas de dosagem em microemulsão de valsartan e métodos para a produção das mesmas - Google Patents

Formas de dosagem em microemulsão de valsartan e métodos para a produção das mesmas

Info

Publication number
BRPI0720077A2
BRPI0720077A2 BRPI0720077-3A2A BRPI0720077A BRPI0720077A2 BR PI0720077 A2 BRPI0720077 A2 BR PI0720077A2 BR PI0720077 A BRPI0720077 A BR PI0720077A BR PI0720077 A2 BRPI0720077 A2 BR PI0720077A2
Authority
BR
Brazil
Prior art keywords
valsartan
methods
dosage forms
same production
microemulsion dosage
Prior art date
Application number
BRPI0720077-3A2A
Other languages
English (en)
Inventor
Yatindra Joshi
John Joseph Kennedy
Ping Li
Alan Edward Royce
Robert Frank Wagner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0720077A2 publication Critical patent/BRPI0720077A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
BRPI0720077-3A2A 2006-12-05 2007-12-03 Formas de dosagem em microemulsão de valsartan e métodos para a produção das mesmas BRPI0720077A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86860406P 2006-12-05 2006-12-05
PCT/US2007/086226 WO2008073731A2 (en) 2006-12-05 2007-12-03 Microemulsion dosage forms of valsartan and methods of making the same

Publications (1)

Publication Number Publication Date
BRPI0720077A2 true BRPI0720077A2 (pt) 2013-12-24

Family

ID=39365945

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0720077-3A2A BRPI0720077A2 (pt) 2006-12-05 2007-12-03 Formas de dosagem em microemulsão de valsartan e métodos para a produção das mesmas

Country Status (15)

Country Link
US (1) US20100035949A1 (pt)
EP (1) EP2111217A2 (pt)
JP (1) JP2010511722A (pt)
KR (1) KR20090086281A (pt)
CN (1) CN101541306A (pt)
AR (1) AR064104A1 (pt)
AU (1) AU2007333355B2 (pt)
BR (1) BRPI0720077A2 (pt)
CA (1) CA2671495A1 (pt)
CL (1) CL2007003484A1 (pt)
MX (1) MX2009005947A (pt)
PE (1) PE20081443A1 (pt)
RU (1) RU2009125613A (pt)
TW (1) TW200840596A (pt)
WO (1) WO2008073731A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013512948A (ja) * 2009-12-08 2013-04-18 イル・ファ・カンパニー・リミテッド ２０−Ｏ−β−Ｄ−グルコピラノシル−２０（Ｓ）−プロトパナキサジオールを含む固体分散体
WO2014009434A1 (en) 2012-07-11 2014-01-16 Sandoz Ag Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate
RU2742650C2 (ru) * 2015-12-09 2021-02-09 Фосфейдженикс Лимитед Фармацевтический состав
CN114712308A (zh) 2015-12-09 2022-07-08 磷肌酸有限公司 药物制剂
EP3558903B1 (en) 2016-12-21 2024-07-03 Avecho Biotechnology Limited Process for phosphorylating a complex alcohol
KR101920628B1 (ko) * 2017-04-12 2018-11-22 대원제약주식회사 안지오텐신 수용체 길항제를 포함하는 약제학적 조성물
CN111183991A (zh) * 2020-03-03 2020-05-22 安徽金敦福农业科技有限公司 一种含有百里香酚的农药组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US20020132839A1 (en) * 2000-06-22 2002-09-19 Ganter Sabina Maria Tablet formulations comprising valsartan
BRPI0518239A2 (pt) * 2004-10-29 2008-11-11 Novartis Ag composiÇÕes farmacÊuticas espontaneamente dispersÍveis
JP2008536929A (ja) * 2005-04-18 2008-09-11 ルビコン・リサーチ・ピーヴィーティー・エルティーディー 生体強化組成物

Also Published As

Publication number Publication date
TW200840596A (en) 2008-10-16
CL2007003484A1 (es) 2008-07-11
AR064104A1 (es) 2009-03-11
JP2010511722A (ja) 2010-04-15
CA2671495A1 (en) 2008-06-19
PE20081443A1 (es) 2008-12-23
WO2008073731A2 (en) 2008-06-19
EP2111217A2 (en) 2009-10-28
WO2008073731A3 (en) 2009-03-19
CN101541306A (zh) 2009-09-23
MX2009005947A (es) 2009-06-17
KR20090086281A (ko) 2009-08-11
AU2007333355A1 (en) 2008-06-19
US20100035949A1 (en) 2010-02-11
AU2007333355B2 (en) 2011-10-20
RU2009125613A (ru) 2011-01-20

Similar Documents

Publication Publication Date Title
NO2023047I1 (no) Cedazuridine, or a pharmaceutically acceptable salt thereof
NO2020038I1 (no) Ozanimod, or a pharmaceutically acceptable salt thereof, including the hydrochloride salt
NO2019042I1 (no) Talazoparib, eventuelt i form av et farmasøytisk aksepterbart salt
NO2018028I1 (no) Alogliptin i kombinasjon med plaglitazon, hver eventuelt i form av et farmasøytisk akseptabelt salt derav
NO2016016I2 (no) Lesinurad, eller et farmasøytisk akseptabelt salt derav
BRPI0812712A2 (pt) produto, processo para produzir o produto, e, uso do produto
BRPI0821276A2 (pt) Produto, e, uso do produto
BRPI0815138A2 (pt) Métodos e organismos para a produção acoplada a crescimento de 1,4-butanodiol
BRPI0817637A2 (pt) anticorpo anti-glipican-3 tendo cinéticas aperfeiçoadas no plasma
BRPI0906957A2 (pt) Aerogéis de carbono, processo para a sua preparação e seu uso
EP2126940A4 (en) ERROR TOLERANT MATERIALS AND METHOD FOR THE PRODUCTION THEREOF
BRPI0806943A2 (pt) Utensílio de dispensação e método de fabricação para o mesmo
PL2112972T3 (pl) Nowe materiały kompozytowe, sposób ich wytwarzania i ich zastosowanie
BRPI0811805A2 (pt) "artigo absorvente alongado e método para sua fabricação".
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
BRPI0820548A2 (pt) Métodos para a formação de artigos microsporosos e microbicidas
BRPI0815796A2 (pt) Compósito elastomérico e método para produzi-lo.
BRPI0808813A2 (pt) método para a preparação de compostos de borracha, e, uso de compostos
EP2023715A4 (en) Indoleamine-2,3-dioxygenase 2
BRPI0811342A2 (pt) "tampão e método de fabricação de um tampão em forma cilíndrica".
BRPI0720077A2 (pt) Formas de dosagem em microemulsão de valsartan e métodos para a produção das mesmas
IL193155A0 (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
BRPI0718068A2 (pt) Material compósito, e, método
BRPI0811266A2 (pt) Método de acupuntura e uma agulha para realizar o mesmo.
BRPI0814074A2 (pt) Método para a fabricação de 4-isopropil-3-metilfenol e sua utilização

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A E 6A ANUIDADES.

B08I Application fees: publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.